Skip to main content
. Author manuscript; available in PMC: 2022 Feb 9.
Published in final edited form as: Expert Rev Vaccines. 2017 Dec 29;17(2):145–161. doi: 10.1080/14760584.2018.1418665

Table 3.

Rotarix IgA seroconversion with and without abstention from breastfeeding at the time of vaccinationa.

Reference Location Income groupd Vaccine RV1 IgA seroconversion post dose 2
p-Value
Withholding breastfeedingb Non-withholding breastfeedingc
Rongsen-Chandola et al. 2014 [55] India LM RV1 26% 27% NS
Ali et al. 2015 [61] Pakistan LM RV1 28% 38% NS
Groome et al. 2014 [60] South Africa UM RV1 63% 58% NS

SC: seroconversion, RV1: Rotarix, NS: Non-statistically significant (p > 0.05).

a

Post licensure randomized control trials.

b

Abstention from breastfeeding for at least 30 or 60 min before and after each dose or Rotarix.

c

Unrestricted breastfeeding was encouraged.

d

World Bank list of economies (December 2016) low-income (L); lower middle-income (LM); upper middle-income (UM); high-income (H).